Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 23:
Par Pacific Holdings, Inc. PARR: This energy and infrastructure business has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 100.6% over the last 60 days.
Par Pacific Holdings, Inc. Price and Consensus
Par Pacific Holdings, Inc. price-consensus-chart | Par Pacific Holdings, Inc. Quote
Par Pacific’s shares gained 17.5% over the last three months compared with the S&P 500’s advance of 6%. The company possesses a Momentum Score of A.
Par Pacific Holdings, Inc. Price
Par Pacific Holdings, Inc. price | Par Pacific Holdings, Inc. Quote
Chemomab Therapeutics Ltd. CMMB: This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 70% over the last 60 days.
Chemomab Therapeutics Ltd. Sponsored ADR Price and Consensus
Chemomab Therapeutics Ltd. Sponsored ADR price-consensus-chart | Chemomab Therapeutics Ltd. Sponsored ADR Quote
Chemomab’s shares gained 18.9% over the last month compared with the S&P 500’s advance of 1.7%. The company possesses a Momentum Score of A.
Chemomab Therapeutics Ltd. Sponsored ADR Price
Chemomab Therapeutics Ltd. Sponsored ADR price | Chemomab Therapeutics Ltd. Sponsored ADR Quote
Guess?, Inc. GES: This apparel and accessories company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Guess?, Inc. Price and Consensus
Guess?, Inc. price-consensus-chart | Guess?, Inc. Quote
Guess’ shares gained 27.4% over the last three months compared with the S&P 500’s advance of 6%. The company possesses a Momentum Score of B.
Guess?, Inc. Price
Guess?, Inc. price | Guess?, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Guess?, Inc. (GES): Free Stock Analysis Report Par Pacific Holdings, Inc. (PARR): Free Stock Analysis Report Chemomab Therapeutics Ltd. Sponsored ADR (CMMB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research